EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

[18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT

Xingyu Mu, Xiaoxue Huang, Zewen Jiang, Meng Li, Lulu Jia, Zhongyuan Lv, Wei Fu, Jingsong Mao

European Journal of Nuclear Medicine and Molecular Imaging · 2023-03 · 50 (4) · 1205-1215

DOI: 10.1007/s00259-022-06067-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 10.12.2022. Verfasst von Xingyu Mu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Affiliated Hospital, Guilin Medical University, Guilin, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to assess the diagnostic performance of [ 18 F]FAPI-42 PET/CT and compare it with that of 2-[ 18 F]FDG PET/CT in patients with differentiated thyroid cancer (DTC) with biochemical elevations in Tg or anti-Tg antibodies.

Methods

A total of 42 patients with DTC with biochemical elevations in Tg or anti-Tg antibodies underwent [ 18 F]FAPI-42 PET/CT as part of this study; of which, 11 additionally underwent 2-[ 18 F]FDG PET/CT within 7 days. Images were semi-quantitatively and visually interpreted, and the quantity, location, and uptake values of lesions were noted. The diagnostic capacity of [ 18 F]FAPI-42 PET/CT and biomarkers affecting the uptake of [ 18 F]FAPI-42 were evaluated. In addition, the diagnostic performance and uptake of [ 18 F]FAPI-42 and 2-[ 18 F]FDG were compared, and the correlation between lesion diameter and quantitative parameters was investigated.

Results

A total of 161 lesions were detected in 27 (64%) patients on [ 18 F]FAPI-42 PET/CT. FAPI-positive local recurrence showed the highest uptake intensity, followed by lymphatic, other site-associated (bone and pleura), and pulmonary lesions (mean SUV max , 4.7 versus 3.7 versus 3.0 versus 2.2, respectively; P < 0.0001). The levels of TSH, Tg, and Tg-Ab did not affect the uptake value of lesions (median SUV max : 2.4 versus 3.2, P = 0.56; 2.9 versus 2.4, P = 0.0935; 2.8 versus 2.6, P = 0.0525, respectively). A total of 90 positive lesions were detected in 7 patients using both modalities. All positive lesions showed statistically higher uptake of 2-[ 18 F]FDG than that of [ 18 F]FAPI-42 (SUV max , 2.6 versus 2.1; P = 0.026). However, the SUV max of [ 18 F]FAPI-42 was higher than that of 2-[ 18 F]FDG in local recurrences and lymphatic lesions (SUV max , 4.2 versus 2.9 and 3.9 versus 3.4, respectively; P > 0.05). Conclusion [ 18 F]FAPI-42 can be used for detecting lesions and reflecting FAP expression during local recurrence and metastasis in patients with DTC with biochemical elevations in Tg or anti-Tg antibodies. The diagnostic performance of [ 18 F]FAPI-42 PET/CT is comparable with that of 2-[ 18 F]FDG PET/CT in such patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAdenocarcinomaHumansPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Positron-Emission TomographyGallium Radioisotopes

Stichwörter der Autor:innen

2-[18F]FDGDifferentiated thyroid cancerPET/CT[18F]FAPI-42

Substanzen

Fluorodeoxyglucose F18Gallium Radioisotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Affiliated Hospital, Guilin Medical University, Guilin, China.
  • Department of Vascular Intervention, Affiliated Hospital, Guilin Medical University, Guilin, China.
  • Department of Nuclear Medicine, Affiliated Hospital, Guilin Medical University, Guilin, China. fuwei19700513@163.com.
  • Department of Vascular Intervention, Affiliated Hospital, Guilin Medical University, Guilin, China. maojingsong163@163.com.
  • Xiamen Key Laboratory of Endocrine-Related Cancer Precision Medicine, Xiamen, 361101, China. maojingsong163@163.com.

Zitieren

APA

Mu, X., Huang, X., Jiang, Z., Li, M., Jia, L., Lv, Z., Fu, W., & Mao, J. (2023). [18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 50(4), 1205-1215. https://doi.org/10.1007/s00259-022-06067-2

Vancouver

Mu X, Huang X, Jiang Z, Li M, Jia L, Lv Z, et al. [18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 2023;50(4):1205-1215. doi:10.1007/s00259-022-06067-2

BibTeX
@article{Mu2023,
  author = {Mu, Xingyu and Huang, Xiaoxue and Jiang, Zewen and Li, Meng and Jia, Lulu and Lv, Zhongyuan and Fu, Wei and Mao, Jingsong},
  title = {[18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  volume = {50},
  number = {4},
  pages = {1205--1215},
  doi = {10.1007/s00259-022-06067-2}
}
Kostenlos starten →